2024 Q1 Form 10-K Financial Statement

#000121465924002110 Filed on February 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $6.118M $10.55M $30.64M
YoY Change -1.16% 38.95% 10.27%
Cost Of Revenue $3.504M $6.656M $19.75M
YoY Change -11.04% 55.33% 27.67%
Gross Profit $2.614M $3.892M $10.89M
YoY Change 16.13% 17.73% -11.59%
Gross Profit Margin 42.73% 36.9% 35.53%
Selling, General & Admin $1.912M $2.272M $8.105M
YoY Change 5.87% 20.53% 4.8%
% of Gross Profit 73.14% 58.38% 74.46%
Research & Development $494.0K $493.0K $2.224M
YoY Change -24.23% -24.96% 1.51%
% of Gross Profit 18.9% 12.67% 20.43%
Depreciation & Amortization $265.0K $275.0K $925.0K
YoY Change 157.28% 183.51% 134.77%
% of Gross Profit 10.14% 7.07% 8.5%
Operating Expenses $2.406M $2.765M $10.33M
YoY Change -2.12% 8.77% 4.07%
Operating Profit $208.0K $1.127M $556.0K
YoY Change -200.48% 47.51% -76.71%
Interest Expense -$142.0K $148.0K $386.0K
YoY Change 5.71% 175.71%
% of Operating Profit -68.27% 13.13% 69.42%
Other Income/Expense, Net $147.0K -$96.00K $122.0K
YoY Change 5.76% -2020.0% -87.45%
Pretax Income $213.0K $1.179M $826.0K
YoY Change -413.24% 29.7% -76.39%
Income Tax $36.00K $176.0K $194.0K
% Of Pretax Income 16.9% 14.93% 23.49%
Net Earnings $177.0K $1.003M $632.0K
YoY Change -416.07% 37.96% -77.32%
Net Earnings / Revenue 2.89% 9.51% 2.06%
Basic Earnings Per Share $0.07 $0.24
Diluted Earnings Per Share $0.07 $0.37 $0.24
COMMON SHARES
Basic Shares Outstanding 2.578M shares 2.578M shares 2.578M shares
Diluted Shares Outstanding 2.610M shares 2.610M shares

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $9.869M $10.30M $10.30M
YoY Change -25.48% -33.01% -33.01%
Cash & Equivalents $9.869M $10.30M $10.30M
Short-Term Investments
Other Short-Term Assets $280.0K $487.0K $487.0K
YoY Change -52.86% -13.65% -13.65%
Inventory $14.50M $11.48M $11.48M
Prepaid Expenses
Receivables $5.174M $8.328M $8.328M
Other Receivables $120.0K $139.0K $139.0K
Total Short-Term Assets $29.94M $30.73M $30.73M
YoY Change 1.06% -1.49% -1.49%
LONG-TERM ASSETS
Property, Plant & Equipment $23.87M $24.10M $24.10M
YoY Change 4.87% 7.28% 7.22%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $475.0K $475.0K $475.0K
YoY Change 452.33% 452.33% 452.33%
Total Long-Term Assets $24.35M $24.57M $24.57M
YoY Change 6.56% 8.91% 8.91%
TOTAL ASSETS
Total Short-Term Assets $29.94M $30.73M $30.73M
Total Long-Term Assets $24.35M $24.57M $24.57M
Total Assets $54.29M $55.31M $55.31M
YoY Change 3.45% 2.87% 2.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.900M $1.491M $1.491M
YoY Change 29.34% 27.11% 27.11%
Accrued Expenses $1.011M $1.738M $1.738M
YoY Change 1.3% 2.66% 2.66%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $432.0K $0.00
YoY Change -100.0% 92.86% -100.0%
Long-Term Debt Due $436.0K $432.0K $432.0K
YoY Change 93.78% 92.86% 92.86%
Total Short-Term Liabilities $3.853M $4.723M $4.723M
YoY Change 14.57% 6.59% 6.59%
LONG-TERM LIABILITIES
Long-Term Debt $15.21M $15.32M $15.32M
YoY Change 3.95% 5.37% 5.37%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $15.21M $15.32M $15.32M
YoY Change 3.95% 5.37% 5.37%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.853M $4.723M $4.723M
Total Long-Term Liabilities $15.21M $15.32M $15.32M
Total Liabilities $19.07M $20.04M $20.04M
YoY Change 5.93% 5.66% 5.66%
SHAREHOLDERS EQUITY
Retained Earnings $35.15M $35.23M
YoY Change 1.76% 1.07%
Common Stock $308.0K $308.0K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.250M $1.250M
YoY Change 0.0% 0.0%
Treasury Stock Shares
Shareholders Equity $35.23M $35.27M $35.27M
YoY Change
Total Liabilities & Shareholders Equity $54.29M $55.31M $55.31M
YoY Change 3.45% 2.87% 2.87%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income $177.0K $1.003M $632.0K
YoY Change -416.07% 37.96% -77.32%
Depreciation, Depletion And Amortization $265.0K $275.0K $925.0K
YoY Change 157.28% 183.51% 134.77%
Cash From Operating Activities -$29.00K -$985.0K -$3.196M
YoY Change -98.06% -250.38% -245.01%
INVESTING ACTIVITIES
Capital Expenditures $40.00K $54.00K $2.560M
YoY Change -91.67% -95.79% -80.63%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$40.00K -$54.00K -$2.560M
YoY Change -91.67% -95.79% -80.63%
FINANCING ACTIVITIES
Cash Dividend Paid $258.0K $258.0K
YoY Change 0.0% 0.0%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $103.0K $275.0K
YoY Change
Cash From Financing Activities -361.0K -111.0K $680.0K
YoY Change 128.48% -127.75% -93.89%
NET CHANGE
Cash From Operating Activities -29.00K -985.0K -$3.196M
Cash From Investing Activities -40.00K -54.00K -$2.560M
Cash From Financing Activities -361.0K -111.0K $680.0K
Net Change In Cash -430.0K -1.150M -$5.076M
YoY Change -79.82% 406.61% -4226.83%
FREE CASH FLOW
Cash From Operating Activities -$29.00K -$985.0K -$3.196M
Capital Expenditures $40.00K $54.00K $2.560M
Free Cash Flow -$69.00K -$1.039M -$5.756M
YoY Change -96.5% 65.71% -47.72%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0000065759
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
usd
CY2022 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
usd
CY2022 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
usd
CY2022 MPAD Restricted Stock Units
RestrictedStockUnits
shares
CY2022Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
usd
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-11-30
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--11-30
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
000-5109
CY2023 dei Entity Registrant Name
EntityRegistrantName
Micropac Industries, Inc.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
75-1225149
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
1655 State Highway 66
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Garland
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
75040
CY2023 dei City Area Code
CityAreaCode
972
CY2023 dei Local Phone Number
LocalPhoneNumber
272-3571
CY2023 dei Security12b Title
Security12bTitle
Common Stock, $0.10 par value per share
CY2023 dei Trading Symbol
TradingSymbol
MPAD
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
7304856 usd
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2578315 shares
CY2023 dei Auditor Firm
AuditorFirmId
726
CY2023 dei Auditor Name
AuditorName
Whitley Penn LLP
CY2023 dei Auditor Location
AuditorLocation
Plano, Texas
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10299000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15375000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
CY2023Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
8021000 usd
CY2022Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
3644000 usd
CY2023Q4 us-gaap Income Tax Receivable
IncomeTaxReceivable
139000 usd
CY2022Q4 us-gaap Income Tax Receivable
IncomeTaxReceivable
920000 usd
CY2023Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
307000 usd
CY2022Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
408000 usd
CY2023Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
7367000 usd
CY2022Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
6715000 usd
CY2023Q4 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
4113000 usd
CY2022Q4 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
3573000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
11480000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
10288000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
487000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
564000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
30733000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
31199000 usd
CY2023Q4 us-gaap Land
Land
1518000 usd
CY2022Q4 us-gaap Land
Land
1518000 usd
CY2023Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
21013000 usd
CY2022Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
498000 usd
CY2023Q4 us-gaap Inventory Buildings And Improvements
InventoryBuildingsAndImprovements
1126000 usd
CY2022Q4 us-gaap Inventory Buildings And Improvements
InventoryBuildingsAndImprovements
1126000 usd
CY2023Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
2068000 usd
CY2022Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
1036000 usd
CY2023Q4 us-gaap Flight Equipment Net
FlightEquipmentNet
181000 usd
CY2022Q4 us-gaap Flight Equipment Net
FlightEquipmentNet
19415000 usd
CY2023Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
10175000 usd
CY2022Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
9952000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
36081000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
33545000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
11982000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
11082000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24099000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22463000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
14000 usd
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
475000 usd
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
86000 usd
CY2023Q4 us-gaap Assets
Assets
55307000 usd
CY2022Q4 us-gaap Assets
Assets
53762000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1491000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1173000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
958000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1086000 usd
CY2023Q4 us-gaap Deferred Revenue
DeferredRevenue
618000 usd
CY2022Q4 us-gaap Deferred Revenue
DeferredRevenue
1192000 usd
CY2023Q4 MPAD Property Taxes
PropertyTaxes
746000 usd
CY2022Q4 MPAD Property Taxes
PropertyTaxes
560000 usd
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
444000 usd
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
149000 usd
CY2023Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
432000 usd
CY2022Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
224000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
34000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
47000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4723000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4431000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
15316000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
14535000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
20039000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
18966000 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3078315 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3078315 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2578315 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2578315 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
308000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
308000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
983000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
885000 usd
CY2023Q4 MPAD Treasury Stock Share
TreasuryStockShare
500000 shares
CY2022Q4 MPAD Treasury Stock Share
TreasuryStockShare
500000 shares
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
1250000 usd
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
1250000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
35227000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
34853000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
35268000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
34796000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
55307000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
53762000 usd
CY2023 us-gaap Revenues
Revenues
30639000 usd
CY2022 us-gaap Revenues
Revenues
27785000 usd
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
19754000 usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
15473000 usd
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2224000 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2191000 usd
CY2023 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8105000 usd
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7734000 usd
CY2023 us-gaap Costs And Expenses
CostsAndExpenses
30083000 usd
CY2022 us-gaap Costs And Expenses
CostsAndExpenses
25398000 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
556000 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
2387000 usd
CY2023 us-gaap Investment Income Interest
InvestmentIncomeInterest
534000 usd
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
141000 usd
CY2023 us-gaap Interest Expense
InterestExpense
386000 usd
CY2022 us-gaap Interest Expense
InterestExpense
1000 usd
CY2023 us-gaap Other Income
OtherIncome
122000 usd
CY2022 us-gaap Other Income
OtherIncome
972000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
826000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3499000 usd
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
583000 usd
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
814000 usd
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-389000 usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-102000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
194000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
712000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
632000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
2787000 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.24
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.08
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2578315 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2578315 shares
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.24
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.08
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2609509 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2578315 shares
CY2023 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.10
CY2022 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.10
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
32267000 usd
CY2022 us-gaap Dividends
Dividends
258000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
2787000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
34796000 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
98000 usd
CY2023 us-gaap Dividends
Dividends
258000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
632000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
35268000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
632000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
2787000 usd
CY2023 us-gaap Depreciation
Depreciation
925000 usd
CY2022 us-gaap Depreciation
Depreciation
394000 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
98000 usd
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-389000 usd
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-102000 usd
CY2023 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
43000 usd
CY2023 MPAD Increase Decreasein Right Useof Asset
IncreaseDecreaseinRightUseofAsset
-13000 usd
CY2022 MPAD Increase Decreasein Right Useof Asset
IncreaseDecreaseinRightUseofAsset
-53000 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4377000 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1330000 usd
CY2023 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-781000 usd
CY2022 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
920000 usd
CY2023 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-101000 usd
CY2022 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-195000 usd
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1192000 usd
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1604000 usd
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-77000 usd
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
223000 usd
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
319000 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
403000 usd
CY2023 MPAD Increase Decrease In Accrued Compensation
IncreaseDecreaseInAccruedCompensation
128000 usd
CY2022 MPAD Increase Decrease In Accrued Compensation
IncreaseDecreaseInAccruedCompensation
209000 usd
CY2023 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-574000 usd
CY2022 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-66000 usd
CY2023 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
295000 usd
CY2022 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-30000 usd
CY2023 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-14000 usd
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-53000 usd
CY2023 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
194000 usd
CY2022 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
249000 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3196000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2204000 usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2560000 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
13213000 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2560000 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-13213000 usd
CY2023 us-gaap Payments Of Dividends
PaymentsOfDividends
258000 usd
CY2022 us-gaap Payments Of Dividends
PaymentsOfDividends
258000 usd
CY2023 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
1213000 usd
CY2022 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
11390000 usd
CY2023 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
275000 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
680000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
11132000 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-5076000 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
123000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15375000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15252000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10299000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15375000 usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
312000 usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
845000 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
539000 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
373000 usd
CY2023 MPAD Accrued Additions Property Plant Equipment
AccruedAdditionsPropertyPlantEquipment
4000 usd
CY2022 MPAD Accrued Additions Property Plant Equipment
AccruedAdditionsPropertyPlantEquipment
44000 usd
CY2023 us-gaap Revenues
Revenues
30639000 usd
CY2022 us-gaap Revenues
Revenues
27785000 usd
CY2023 us-gaap Revenues
Revenues
30639000 usd
CY2022 us-gaap Revenues
Revenues
27785000 usd
CY2023 MPAD Domestic Direct
DomesticDirect
18740000 usd
CY2023 MPAD Domestic Distrbution
DomesticDistrbution
10070000 usd
CY2023 MPAD International Distribution
InternationalDistribution
1829000 usd
CY2023 us-gaap Revenues
Revenues
30639000 usd
CY2022 MPAD Domestic Direct
DomesticDirect
16433000 usd
CY2022 MPAD Domestic Distrbution
DomesticDistrbution
10330000 usd
CY2022 MPAD International Distribution
InternationalDistribution
1022000 usd
CY2022 us-gaap Revenues
Revenues
27785000 usd
CY2023Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
8021000 usd
CY2022Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
3644000 usd
CY2021Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
4974000 usd
CY2023Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
307000 usd
CY2022Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
408000 usd
CY2021Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
603000 usd
CY2023Q4 us-gaap Deferred Revenue
DeferredRevenue
618000 usd
CY2022Q4 us-gaap Deferred Revenue
DeferredRevenue
1192000 usd
CY2021Q4 us-gaap Deferred Revenue
DeferredRevenue
1258000 usd
CY2023 MPAD Deferred Revenue Recognized
DeferredRevenueRecognized
1169000 usd
CY2023Q4 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0 usd
CY2022Q4 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0 usd
CY2023Q4 us-gaap Notes Payable
NotesPayable
15884000 usd
CY2022Q4 us-gaap Notes Payable
NotesPayable
14938000 usd
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2578315 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2578315 shares
CY2023 MPAD Restricted Stock Units
RestrictedStockUnits
31194 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2609509 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2578315 shares
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_842_eus-gaap--UseOfEstimates_ztkWCBd8czGj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration: underline"><span id="xdx_865_zU412Z3gJOCf">Use of Estimates</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2023Q4 MPAD Fair Value Financial Assets Liabilities Recurring Basis
FairValueFinancialAssetsLiabilitiesRecurringBasis
0 usd
CY2022Q4 MPAD Fair Value Financial Assets Liabilities Recurring Basis
FairValueFinancialAssetsLiabilitiesRecurringBasis
0 usd
CY2023Q4 MPAD Fair Value Non Financial Assets Non Recurring Basis
FairValueNonFinancialAssetsNonRecurringBasis
0 usd
CY2022Q4 MPAD Fair Value Non Financial Assets Non Recurring Basis
FairValueNonFinancialAssetsNonRecurringBasis
0 usd
CY2023Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
136000 usd
CY2022Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
179000 usd
CY2023Q4 MPAD Net Debt
NetDebt
15748000 usd
CY2022Q4 MPAD Net Debt
NetDebt
14759000 usd
CY2023Q4 us-gaap Debt Current
DebtCurrent
432000 usd
CY2022Q4 us-gaap Debt Current
DebtCurrent
224000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
15316000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
14535000 usd
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
432000 usd
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
447000 usd
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
463000 usd
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
478000 usd
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
495000 usd
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
13569000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
15884000 usd
CY2023 us-gaap Product Warranty Expense
ProductWarrantyExpense
56000 usd
CY2022 us-gaap Product Warranty Expense
ProductWarrantyExpense
114000 usd
CY2022Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
25000 usd
CY2021Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
25000 usd
CY2023 us-gaap Product Warranty Accrual Additions From Business Acquisition
ProductWarrantyAccrualAdditionsFromBusinessAcquisition
56000 usd
CY2022 us-gaap Product Warranty Accrual Additions From Business Acquisition
ProductWarrantyAccrualAdditionsFromBusinessAcquisition
114000 usd
CY2023 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
56000 usd
CY2022 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
114000 usd
CY2023Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
25000 usd
CY2022Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
25000 usd
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
165000 usd
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
165000 usd
CY2023 us-gaap Operating Lease Expense
OperatingLeaseExpense
14000 usd
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
55000 usd
CY2023Q4 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.0325 pure
CY2023 MPAD Percentage Of Employee Contributions To The Plan Are Matched By The Company At The Amounts Of The Participants Salary
PercentageOfEmployeeContributionsToThePlanAreMatchedByTheCompanyAtTheAmountsOfTheParticipantsSalary
0.06 pure
CY2022 MPAD Percentage Of Employee Contributions To The Plan Are Matched By The Company At The Amounts Of The Participants Salary
PercentageOfEmployeeContributionsToThePlanAreMatchedByTheCompanyAtTheAmountsOfTheParticipantsSalary
0.06 pure
CY2023Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
500000 usd
CY2022Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
476000 usd
CY2023Q4 MPAD Employees Become Vested In Company Contributions After Two Years
EmployeesBecomeVestedInCompanyContributionsAfterTwoYears
0.20 pure
CY2022Q4 MPAD Employees Become Vested In Company Contributions After Two Years
EmployeesBecomeVestedInCompanyContributionsAfterTwoYears
0.20 pure
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
514000 usd
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
744000 usd
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
69000 usd
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
70000 usd
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
583000 usd
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
814000 usd
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-389000 usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-102000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
194000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
712000 usd
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
177000 usd
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
734000 usd
CY2023 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
54000 usd
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
55000 usd
CY2023 us-gaap Income Tax Credits And Adjustments
IncomeTaxCreditsAndAdjustments
-116000 usd
CY2022 us-gaap Income Tax Credits And Adjustments
IncomeTaxCreditsAndAdjustments
-156000 usd
CY2023 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
79000 usd
CY2022 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
79000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
194000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
712000 usd
CY2023Q4 us-gaap Inventory Gross
InventoryGross
330000 usd
CY2022Q4 us-gaap Inventory Gross
InventoryGross
265000 usd
CY2023Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
420000 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Returns And Allowances
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances
5000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Returns And Allowances
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances
5000 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
100000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
83000 usd
CY2023Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
380000 usd
CY2022Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
267000 usd
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
475000 usd
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
86000 usd
CY2023Q4 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0 usd
CY2022Q4 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0 usd
CY2023Q4 MPAD Sale To Government
SaleToGovernment
0.74 pure
CY2022Q4 MPAD Sale To Government
SaleToGovernment
0.77 pure
CY2023 us-gaap Dividends Payable Date Declared Day Month And Year
DividendsPayableDateDeclaredDayMonthAndYear
2022-12-07
CY2023 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.10
CY2023 us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2023-01-11
CY2023 us-gaap Dividend Payable Date To Be Paid Day Month And Year
DividendPayableDateToBePaidDayMonthAndYear
2023-02-10
CY2022 us-gaap Dividends Payable Date Declared Day Month And Year
DividendsPayableDateDeclaredDayMonthAndYear
2021-12-07
CY2022 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.10
CY2022 us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2022-01-11
CY2022 us-gaap Dividend Payable Date To Be Paid Day Month And Year
DividendPayableDateToBePaidDayMonthAndYear
2022-02-10
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
98000 usd
CY2023Q4 MPAD Stockbased Unvested Compensation Expense For Second Year
StockbasedUnvestedCompensationExpenseForSecondYear
156000 usd
CY2023Q4 MPAD Stockbased Unvested Compensation Expense For Third Year
StockbasedUnvestedCompensationExpenseForThirdYear
156000 usd
CY2023Q4 MPAD Stockbased Unvested Compensation Expense
StockbasedUnvestedCompensationExpense
312000 usd
CY2021Q1 MPAD Employee Retention Credits
EmployeeRetentionCredits
920000 usd
CY2023 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001214659-24-002110-index-headers.html Edgar Link pending
0001214659-24-002110-index.html Edgar Link pending
0001214659-24-002110.txt Edgar Link pending
0001214659-24-002110-xbrl.zip Edgar Link pending
ex31_1.htm Edgar Link pending
ex31_2.htm Edgar Link pending
ex32_1.htm Edgar Link pending
ex32_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mpad-20231130.xsd Edgar Link pending
p2624510k.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
mpad-20231130_def.xml Edgar Link unprocessable
mpad-20231130_cal.xml Edgar Link unprocessable
mpad-20231130_pre.xml Edgar Link unprocessable
mpad-20231130_lab.xml Edgar Link unprocessable
p2624510k_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending